Mercredi 16 décembre 2026 de 9h à 16h15, et jeudi 17 décembre 2026 de 9h à 16h
Conférence en anglais.
Cette formation a pour but le partage d’expériences sur le traitement du cancer de la prostate entre deux pays et deux cultures différentes.
Programme
Module 1 - Mercredi 16 décembre
09:00-10:15 : part 1
Moderators:
Dr. Bülent Karabulut
Pr. Alfredo Addeo, M.D., head of Medical oncology division, HUG
- 09:00-09:15 Opening session
Dr. Bülent Karabulut
Pr. Alfredo Addeo, M.D., head of Medical oncology division, HUG - 09:15-09:45 The role of active surveillance
Dr D. Benamran, staff physician, Urology division, HUG - 09:45-10:15 PET PSMA in prostate cancer
Pre Valentina Garibotto, M.D., head of Nuclear medicine division, HUG - 10:15-10:30 Coffee Break
10:30-12:00 :part 2
Moderator: Pr. Dr. Mustafa Erman
- 10:30-11:00 Prostatectomy in localized prostate cancer
Pr Massimo Valerio, M.D., head of Urology division and Prostate centre, HUG - 11:00-11:30 Radiotherapy in localized prostate cancer
Pr A. Papachristofilou (USB, to be confirmed) - 11:30-12:00 New paradigms and future directions in metastatic prostate cancer treatment
Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG - 12:00-13:00 Lunch Break
13:00-14:30 : part 3
Moderator: Pr Dr Deniz Tural
- 13:00-13:30 The role of RMN in localized and metastatic prostate cancer
Dr Thomas De Perrot, radiologist, Prostate centre, HUG - 13:00-14:30
- mHSPC Low volume: multidisciplinary approach
Dr Dominik Berthold, oncologist, head of Prostate ceentre, CHUV - mHSPC – High volume: Defining the standard of care
Dr Emre Yekedüz
- mHSPC Low volume: multidisciplinary approach
- 14:30-14:45 Coffee Break
14:45-16:15 : part 4
Moderator:
Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG
Dr Gökşen İnanç İmamoğlu
- 14:45-15:15 ARPIs in prostate cancer: patient selection and personalized treatment
Dr Gökşen İnanç İmamoğlu - 15:15-16:15 Clinical scenarios and discussion
Dr Maxime Borgeaud, M.D., senior resident, Medical oncology division, HUG
Module 2 – jeudi 17 décembre
09:00-10:30 : part 1
Moderator: Dr Umut Varol
- 09:00-09:30 Radioligand therapy in prostate cancer: new standards & future directions
Dr Nicola Bianchetto M.D., Senior Resident, Nuclear medicine division, HUG) - 09:30-10:00 Castration-Resistant Prostate Cancer: Sequencing and Precision Treatment
Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG - 10:00-10:30 RECIST and PCWG3 – clinical practice and trials
Dr Umut Varol - 10:30-10:45 Coffee Break
10:45-12:00 : part 2
Moderator: Dr Meltem Baykara
- 10:45-12:00 Clinical scenarios and discussion
Dr Maxime Borgeaud, M.D., senior resident, Medical oncology division, HUG - 12:00-13:00 Lunch Break
- 13:00-16:00 TTOD Session-Insights and Reflections on Preceptorship
Moderator: Pr Dr Bülent Karabulut
Speakers: Dr Mustafa Erman, Dr Deniz Tural, Dr Gökşen İnanç İmamoğlu, Dr Umut Varol, Dr Meltem Baykara, Dr Emre Yekedüz
Informations pratiques
Formation spécialisée sur le cancer de la prostate
Mercredi 16 décembre 2026 de 9h à 16h15, et jeudi 17 décembre 2026 de 9h à 16h
SWISS Foundation for Innovation and Training in Surgery (SFITS)
Rue Gabrielle-Perret-Gentil 4, 1205 Geneva
Inscription
Places limitées.
Pour vous inscrire, merci d'adresser un email à :